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sensory systems are weighted and at 
which stage the combination takes 
place is still under investigation. 
But it seems that, at least in the fly, 
such integration occurs quite early 
on in the visuo-motor pathways, 
which helps the animal to keep its 
gaze level and remain stable in the 
air during rapid movements but also 
when slowly drifting. 
What is the point in studying the 
ocelli and other insect sensory 
systems? There are two answers to 
that question. For one, using sensory 
information to control balance and 
gaze, or to produce other meaningful 
behaviour, is a common theme 
amongst all animals, including 
humans. As I just mentioned, the 
control of balance and gaze has to 
work at different speeds — which 
is true for flies and humans. For 
instance, flies and humans keep 
their gaze aligned with the external 
horizon, which tremendously 
simplifies the processing of visual 
information. This is because the 
connections in the visual system 
are wired up in a way that assumes 
a certain orientation of the world 
when it is projected onto our eyes. 
Deciphering text when all the words 
are printed upside-down takes 
considerably longer than reading 
upside-up. Although this is an 
extreme example, it nicely illustrates 
how important it is to keep the  
visual environment in its natural 
upside-up orientation. We do it 
by moving our head and our eyes 
relative to our body, while flies can 
move only their heads to solve 
the same task. And yet, there are 
general functional principles that  
are similar in flies and humans. 
For slow gaze stabilization, we 
both use visual information; and 
for fast stabilization we exploit 
mechanosensory signals. The big 
advantage of studying comparatively 
simple animals such as flies is that 
we already know a lot about the 
neural circuits supporting gaze 
stabilization. We even know the 
individual neurons that combine 
ocellar and compound eye signals 
by name; these play a cardinal role 
in stabilization reflexes, in general. 
So, studying the neural mechanisms 
underlying stabilization reflexes in 
flies, where both the behavioural 
and neuronal performance can 
be quantified, may well help our 
understanding of how the same 
task is solved in more complicated 
animals, such as humans.
The other reason why it is 
interesting to study ocelli and 
other sensory systems in insects is 
because biological systems control 
gaze and flight in a fundamentally 
different way from man-made 
technical systems designed to 
achieve the same goal. Technical 
systems, say in aircraft control, 
use only a small number of highly 
accurate sensor measurements 
in combination with heavy super-
computing to come up with 
command signals to ensure flight 
stability. Biological systems follow 
an entirely different approach: they 
take thousands of local, often noisy, 
signals and combine the information 
in a task-specific way, so that the 
combined outcome can be used 
immediately for control purposes. 
They replace the heavy super-
computing stage with clever signal 
integration. A detailed understanding 
of exactly how the nervous systems 
of insects do this may inspire the 
future design of control engineering 
architectures. 
Where can I find out more about 
ocelli?
Goodman, L.J. (1981). Organisation and 
physiology of the insect dorsal ocellar 
system. In: Handbook of Sensory Physiology 
(ed. Autrum H), Vol. VII/6C. Berlin, Heidelberg 
and New York: Springer-Verlag.
Hengstenberg, R. (1991). Gaze control in the 
blowfly Calliphora: A multisensory two-stage 
integration process. Neurosciences 3, 19–29.
Krapp, H.G., and Wicklein, M. (2008). Central 
processing of visual information in insects. 
In: Basbaum A.I, Kaneko A., Shepherd G.M., 
and Westheimer G. (eds) The Senses: A 
Comprehensive Reference. Vol. 1, Vision 
I, Masland R and Albright T.D. (eds.), San 
Diego, Academic Press, pp. 131–204.
Mizunami, M. (1994). Information-processing 
in the insect ocellar system – comparative 
approaches to the evolution of visual 
processing and neural circuits. Adv. Insect 
Physiol. 25,151–265.
Parsons, M.M., Krapp H.G., and Laughlin, S.B. 
(2006). A motion sensitive neuron responds 
to signals from the two visual systems of the 
blowfly, the compound eyes and the ocelli. J. 
Exp. Biol. 209, 4464–4474.
Schuppe, H., and Hengstenberg, R. (1993). 
Optical-properties of the ocelli of Calliphora 
erythrocephala and their role in the dorsal 
light response. J. Comp. Physiol. A 173, 
143–149.
Taylor, G.M., and Krapp, H.G. (2007). Sensory 
systems and flight stability: What do insects 
measure and why? Adv. Insect Physiol. 34, 
231–316.
Department of Bioengineering, Imperial 
College London, South Kensington 
Campus, London SW7 2AZ, UK.  
E-mail: h.g.krapp@imperial.ac.ukThe natural history 
of antibiotics
Jon Clardy1, Michael A. Fischbach2 
and Cameron R. Currie3
Selman Waksman first used the 
word antibiotic as a noun in 1941 to 
describe any small molecule made by 
a microbe that antagonizes the growth 
of other microbes. From 1945–1955 the 
development of penicillin, produced 
by a fungus, along with streptomycin, 
chloramphenicol, and tetracycline, 
produced by soil bacteria, ushered 
in the antibiotic age (Figure 1). Today, 
the evolution of antibiotic resistance 
by important human pathogens has 
rendered these original antibiotics 
and most of their successors largely 
ineffective, and if replacements are not 
found, the golden age of antibiotics will 
soon come to an end. 
Understanding the success 
and failure of antibiotics requires 
understanding their natural history — 
the origins, evolution, and functions of 
the molecular medley that has played 
such an important role in human 
health. Studying their natural history 
could also result in new strategies 
to find novel antibiotics and delay 
resistance to existing ones. 
Assembly from readily available parts
Antibiotics do not look like the 
familiar molecules in beginning 
biochemistry texts; they usually do 
not even resemble each other. In 
spite of these apparent differences, 
they are assembled from the same 
types of building block through 
enzyme catalysed reactions that 
closely resemble those used in 
making proteins, fatty acids, and 
polysaccharides. For example, 
penicillin is derived from a tripeptide 
of three amino acids, two of which are 
proteinogenic (cysteine and valine) 
and one of which is an intermediate 
in lysine metabolism (α-aminoadipate) 
(Figure 1). In conventional polypeptide 
biosynthesis, tRNAs bring the correct 
amino acid building block to a mRNA 
template and peptide bonds are 
formed to generate an amino-acid 
chain with the mRNA-encoded 
sequence. Some peptide precursors to 
antibiotics are biosynthesized this way, 
Primer
Current Biology Vol 19 No 11
R438and the ribosomally encoded peptide 
undergoes enzyme catalysed post-
translational modifications to produce 
the final antibiotic (Figure 1). 
Amino acid-derived antibiotics 
are more frequently produced by 
modular metabolic pathways in 
which the templating function of the 
mRNA is embedded in the order of 
the modules, and specialized carrier 
proteins in each module perform 
the selection function of the tRNAs 
(Figure 1). The first module in the 
pathway selects the amino- terminal 
amino acid (α- aminoadipate in 




Figure 1. Antibiotic biosynthetic pathways.
(A) Penicillin. Each shape represents a separate protein domain, and the domains are organized 
into three modules (red, blue, and green) that comprise a single ten-domain protein. (1) α-ami-
noadipate is selected and activated by the blue module. (2) Activated α-aminoadipate is loaded 
onto the the blue module. (3) Cysteine is selected and activated by the red module. (4) Cysteine 
is linked to the red module and then coupled to the α-aminoadipate linked to the blue module, 
forming a peptide bond and translocating the chain to the red module. (5,6) The process repeats 
with valine on the green module. (7) The chain is released. Post-assembly modifications convert 
the penicillin precursor into penicillin N. (B) Tetracyline. The enzymes iteratively couple C2 build-
ing blocks (colored red, green, and blue) to synthesize a long chain. Three enzymes cyclize the 
polyketone chain into a precursor with four fused rings, and post-assembly modifications con-
vert the precursor into tetracycline. (C) Streptomycin. Three different sets of enzymes convert the 
primary metabolite glucose-6-phosphate into the three building blocks of streptomycin, colored 
blue, red, and green. Two coupling enzymes link these building blocks, and post-assembly modi-
fications turn the nascent trisaccharide into streptomycin. (D) Thiocillin. The last fourteen amino 
acids of a 52-residue peptide undergo thirteen post-translational modifications — including 
cleavage of the 38-residue ‘leader peptide’ — to become thiocillin.selects the carboxy- terminal amino 
acid (valine). The last module also 
releases the tripeptide chain, so that 
auxiliary enzymes in the pathway can 
carry out the functional equivalent of 
post- translational modifications, which 
are typically quite extensive. 
While tRNAs select from a pool of 
standard (proteinogenic) amino acids, 
the nonstandard amino acids found in 
penicillin and other antibiotics need to 
be synthesized by specialized enzymes 
in a just-in-time fashion. The proteins 
of the penicillin pathway fall into 
various functional categories: enzymes 
that make nonstandard building blocks 
such as α-aminoadipate; enzymes 
that form the modules that select and 
stitch these building blocks together; 
enzymes that modify the peptide into 
the functional antibiotic; regulatory 
proteins that ensure the pathway 
is expressed under appropriate 
conditions; and resistance proteins that 
prevent the would-be producer from 
getting killed. In bacteria and fungi, the 
genes for all these proteins are usually 
found on a continuous stretch of DNA. 
Penicillin biosynthesis mimics protein 
biosynthesis in important ways, but the 
macromolecules that carry out the two 
processes are related only in function.
Tetracycline’s biosynthesis is closely 
related to fatty acid biosynthesis, but 
in this case (distantly) related enzymes 
carry out both processes (Figure 1). 
Tetracycline’s core is assembled from a 
starter unit (malonamyl-CoA) and eight 
two-carbon fragments. Streptomycin 
is assembled from sugar monomers 
by close relatives of the sugar linking 
enzymes that make the common 
polysaccharides. Of course, the sugar 
building blocks of streptomycin are 
more exotic than those of cellulose 
or chitin, and, as was the case 
for α- aminoadipate in penicillin 
biosynthesis, they require specialized 
pathways for their production from 
glucose. The enzymes that make these 
unusual sugars are also relatives of 
enzymes used in primary metabolism. 
Antibiotic biosynthesis is modular, 
just like the biosynthetic pathways of 
more familiar biological molecules like 
proteins and DNA. The startling array 
of antibiotic structures arises from a 
more exotic set of starting materials 
and more extensive modifications of 
the polymeric core. 
Modular biosynthetic pathways
The long linear pathways that nature 
uses to assemble antibiotics contrast 
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devise for similarly complex molecules. 
Efficient laboratory syntheses tend to 
avoid long linear reaction sequences, 
because they involve both the logistical 
difficulties inherent in having a long 
supply chain and the likelihood of low 
overall yields — a ten-step sequence 
with a 90% yield in every step results in 
a 35% overall yield. In a microbial cell, 
the catalytic proficiency of enzymes can 
push the yield of any step sufficiently 
close to 100% to tame the arithmetic 
demon that governs overall yields.
The modularity of the pathways — 
one module per subunit from the 
beginning to the end of the molecule — 
enforces a long linear sequence of 
reactions, and nature favors modularity 
to expedite the evolution of molecular 
diversity. Antibiotics are made by highly 
evolvable pathways. Consider the 
penicillin pathway. Each of its modules 
consists of three protein domains: one 
to select an amino-acid building block; 
one to activate it; and one to insert it 
into the growing chain. Three of these 
modules synthesize the tripeptide 
core of penicillin, and the sequence 
of the peptide chain is determined 
by the sequence of the modules. 
Vancomycin, which these days is 
invariably described as the ‘antibiotic of 
last resort’, has seven modules. There 
are many instances where two pairs of 
antibiotics produced by these modular 
pathways differ by the insertion, 
deletion, or replacement of a module. 
A very similar analysis can be 
given for the pathways that produce 
antibiotics like tetracycline, although 
they are based on acetate-derived 
building blocks, not amino acids. 
After the starter unit, each module 
introduces a two-carbon building block 
to the growing linear chain (sometimes 
with a one-carbon side chain; Figure 1). 
The two-carbon fragment can be 
processed in a variety of ways to 
provide distinguishing features to the 
originally identical building blocks. The 
result is a lipid-like molecule rather 
than a peptide, but the modularity 
that facilitates evolutionary molecular 
diversification persists. Antibiotics like 
streptomycin are also assembled in a 
modular fashion; except the building 
blocks are sugars and the coupling 
reactions are the same type that 
assemble glycogen and cellulose.
Because the modular assembly of 
most antibiotics mimics the modular 
assembly of biological macromolecules 
like proteins, all of the same general evolutionary strategies that provide 
for protein diversification — 
mutation, duplication, deletion, and 
rearrangement — are also used to 
evolve new antibiotics. The complex 
suite of antibiotics we see today results 
from rounds of alteration, selection, 
and amplification of simpler ancestors. 
Antibiotic evolution is complicated by 
lineage and function
In principle, the evolutionary history 
of an antibiotic or an antibiotic 
family, say the beta-lactam family 
that includes penicillin, should be a 
wonderful model for the evolution 
of multigenic traits. There is a clear 
phenotype — a molecule — and 
the contribution of each of the gene 
products to forming the final molecule 
is increasingly understood. However, 
tracing a path back from two members 
of an antibiotic family to a common 
ancestor, not to mention the more 
difficult task of tracing the path from 
an early ancestor to today’s family 
members, is complicated by our 
current ignorance of both the pedigree 
of the antibiotic producing genes and 
the ecological role of the antibiotic in 
the producer’s natural community. The 
evolutionary history of bacterial genes, 
especially the genes involved in the 
biosynthesis of antibiotics and other 
secondary metabolites, is shaped by 
horizontal gene transfer. Horizontal 
gene transfer is undoubtedly the 
reason that the genes for regulation, 
resistance and biosynthesis are usually 
clumped together on a continuous 
stretch of DNA. As a result, a microbe’s 
secondary metabolite repertoire 
probably depends more on its 
neighbors than its ancestors. 
Some antibiotic gene clusters are 
cosmopolitan, while others have 
cameo roles. One analysis estimated 
that if 10,000 actinomycetes (the family 
of soil bacteria that has produced most 
of our antibiotics and other medically 
useful molecules) were screened, 2,500 
would produce antibiotics. Of these, 
2,250 would make streptothricin, 125 
streptomycin, and 40 tetracycline. 
Vancomycin is predicted to be made 
by one in a hundred thousand; 
erythromycin, by one in a million; and 
daptomycin, our newest antibiotic, 
by one in ten million. Because the 
soil bacteria that produced so many 
of our antibiotics live in exceptionally 
complex multispecies environments, 
tracing both neighbors and ancestors 
will be a daunting task. Sequenced bacterial genomes are now appearing 
with increasing frequency, and it is 
likely that the genomes of antibiotic-
producing microbes will be sequenced 
at an increased pace in the near future. 
If the past is any guide, they will reveal 
that these familiar microbes produce 
many more molecules than have been 
found using traditional methods, 
which will open up great opportunities 
to tease out the production of the 
cryptic antibiotics. These new genome 
sequences will also allow us to make 
some headway in tracing evolutionary 
histories, or at least suggest plausible 
models.
Another problem with tracing the 
evolutionary history of antibiotics 
is our current ignorance about their 
roles in the natural environment. We 
know what antibiotics can do for us, 
but what do they do for the producing 
organism? Without understanding 
the natural roles of antibiotics, we 
cannot understand the basis for 
their evolutionary selection. Most 
scientists assume that microbes 
produce antibiotic compounds to 
mediate interactions with other 
microbes in their neighborhood. The 
main evidence for this view is the wide 
distribution of antibiotic resistance 
genes: many microbes carry the 
resistance gene for antibiotics that 
they themselves cannot produce, 
from which it follows that resistance 
genes — and by extension the 
molecules to which they confer 
resistance — must have a function. 
An appealing possibility is that 
antibiotics are made by microbes to 
kill competing microbes, but as early 
as 1961, Selman Waksman pointed out 
that the ability of a microbe to produce 
a small molecule with antibiotic 
properties when cultured under 
unnatural conditions in the laboratory 
does not imply such a function for the 
molecule in nature. Recently, it has 
been shown that at concentrations 
well below those needed to inhibit the 
growth of other bacteria, antibiotics can 
modulate the transcriptional profiles 
of target bacteria. These revelations 
have caused several scientists to 
argue that what we call ‘antibiotics’ 
are actually signaling molecules that 
happen to kill bacteria when applied 
at unnaturally high concentrations. In 
this view, the products of resistance 
genes silence messages rather than 
provide protection. In short, we know 
little about the ecological role of the 
molecules we call antibiotics. 
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complicated microbial environments
If our ability to unravel the natural 
history of antibiotics is frustrated by 
the complexity of their producers’ 
environments, a logical recourse is 
finding simpler systems in which 
microbes produce antibiotics. At a 
minimum, the likelihood of finding 
useful new molecules would increase 
by moving our search away from 
explored environments. For example, 
investigations of marine environments 
have provided many microbial-
produced novel small molecules. 
While these molecules are likely to 
contribute new human therapeutic 
agents, the ecology of their marine 
habitats is not understood well 
enough to trace antibiotic phylogeny 
and/or function. In contrast, 
insect–bacteria mutualisms — a 
symbiotic association in which each 
of the participants receives a net 
benefit — appear quite tractable for 
functional and evolutionary analyses. 
An especially attractive system is 
the multilateral symbiosis among 
fungus-growing ants, the fungus they 
cultivate for food, and the bacterial 
symbionts that help protect the ants’ 
fungal crops (Figure 2).
Figure 2. Exploring the natural history of antibiotics by focusing on ancient agriculture in ants.
Fungus-growing ants, including the conspicuous leaf-cutters (A), cultivate fungus for food (B). 
The ants engage in another mutualism with actinomycetes, which can completely cover the 
exoskeleton of workers ((C); whitish substance on Acromyrmex sp.), or occur within special-
ized crypts, on the ventral surface of the ants ((D); propleura in Cyphomyrmex longiscapus) 
and can even cover most of the surface of workers ((E); white dots on exoskeleton of C. long-
iscapus represent openings to crypts). The symbiotic actinomycetes produce antibiotics that 
help protect the garden from specialized parasites in the genus Escovopsis ((F); bioassay with 
bacterium in middle and parasite Escovopsis on the left side). (Photocredits: A,B, Alex Wild; 
C, Ainslie Little.)The relationship between fungus-
growing ants and their food fungus 
first originated some 50 million years 
ago in the Amazon Basin. As the 
name suggests, these ants cultivate 
fungus for food in specialized gardens, 
typically underground. The relationship 
between ants and their food fungus is 
an obligate mutualism: the ants cannot 
survive without their fungal partner, 
and the fungal partner cannot survive 
without the ants. When new queens 
leave their parent colonies, they carry a 
fragment of the fungus with them to the 
site of the new colony. Both ant and 
fungus have prospered: from a single 
pair of founding species this initial 
symbiosis has evolved to include more 
than 230 species of ants and diverse 
fungal strains. In the leaf-cutter ant 
genus Atta, the most derived members 
of the fungus growers, a single colony 
can harbor millions of workers and 
persist for more than a decade. Leaf-
cutter ants use fresh leaf substrate to 
cultivate their fungal partner, and their 
copious foraging activities make them 
one of the dominant herbivores of the 
Neotropics. The phylogeny of the ants 
and their fungal partners is largely 
known, and the evolutionary history of 
the food fungus broadly parallels the 
ant phylogeny — they have undergone 
diffuse co-evolution for tens of millions 
of years. 
The ants engage in a second 
mutualism with bacteria that belong 
to the same order of bacteria 
(actinomycetes) that produce so many 
of our clinically used antibiotics (and 
anticancer agents). In this system, all 
of the known ant-associated bacteria 
belong to the genus Pseudonocardia, 
and the association between the 
ants and their bacterial symbionts 
appears to be an ancient one. The 
strongest evidence for their long-
standing association is the elaborate 
morphological adaptations that the 
ants have evolved for housing their 
bacteria (Figure 2). Different ant genera 
have different types of modification, 
and the structures housing the bacteria 
are connected to glands, which are 
thought to produce nutrients that 
support the growth of the bacteria. 
Ants are highly specialized for their 
bacterial symbionts, and experiments 
to replace an ant’s bacterial symbiont 
with that from another ant have not yet 
been successful. These ant-associated 
bacteria produce antibiotics, which are 
as yet poorly known, that protect the 
ants’ fungal gardens from microbial 
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hue circle, they show the number of 
cells that are maximally excited by 
that hue. There are three peaks in 
the histogram: one (the largest) falls 
close to unique red and another falls 
close to unique blue, while the third 
(less well-defined) lies in the yellow-
green region. In fact, however, if the 
stimuli used in the experiment are 
plotted in a physiological color space, 
they form not a circle but an obtuse 
triangle. The peaks identified by 
Stoughton and Conway [4] fall at the 
apices of this triangle. Because these 
stimuli maximize the ratios of cone 
signals, they would maximally excite 
cells earlier in the visual system. So 
Stoughton and Conway’s polar plot 
does not in itself show that cells of 
the posterior inferior temporal cortex 
represent unique hues, nor that they 
differ qualitatively in their behavior 
from chromatic cells at an earlier level.
The stimuli were presented to the 
monkey on a CRT and the individual 
chromaticities were obtained by 
A neural basis for 
unique hues?
J.D. Mollon
The four perceptually simple colors — 
red, green, yellow and blue — are a 
challenge to neuroscience, because 
no one has found cortical cells that 
represent color in terms of these 
‘unique hues’ [1]. The chromatically 
selective cells at early stages of 
the primate visual system do not 
map on to the unique hues [2,3]. 
Recently, however, Stoughton and 
Conway [4] have reported that the 
peak sensitivities of color cells in 
posterior inferior temporal cortex do 
cluster near the unique hues. The 
authors plot their results as a polar 













Figure 1. Stoughton and Conway’s [4] equiluminant stimulus set (small black points) re-plotted 
in the chromaticity diagram of MacLeod and Boynton (1979).
The colored dots show the chromaticities of the three phosphors of the CRT used in the experi-
ments. Open circle: chromaticity of the white background present during the measurements. 
The arrows indicate the maximum available modulations on the two axes of the diagram. Scal-
ing of S axis as in [8].pathogens. Experimental studies 
crossing the presence/absence of the 
bacteria with the presence/absence 
of a specialized garden pathogen — a 
fungus in the genus Escovopsis — have 
shown that ants with antibiotic-
producing bacteria are better able 
to protect their fungal gardens from 
disease. These studies are among 
the best evidence that at least some 
antibiotics suppress infections in nature. 
The ant–fungus–bacteria mutualism 
is an ancient system whose 
evolutionary histories can be deduced 
by traditional molecular phylogenetic 
studies. Once these histories have 
been established and the associated 
antibiotics have been identified, there 
will be a wealth of data to trace both 
the evolution of these small molecules 
and their function. These studies 
could also reveal how the ant-bacteria 
system has maintained itself over tens 
of millions of years without running out 
of antibiotics to combat the inevitable 
development of antibiotic resistance by 
their microbial pathogens. In short, we 
can learn a lot from bugs — both the 
six-legged and microbial varieties.
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